Director, APAC Evidence & Access Strategy
Posted 75ds ago
Employment Information
Report this job
Job expired or something wrong with this job?
Job Description
Leads evidence and access strategy for Ion business in APAC region. Engaging with cross-functional teams to improve patient outcomes and health-system efficiency.
Responsibilities:
- Set the APAC evidence & access strategy
- Define a 3–5 year clinical and economic evidence roadmap for Ion in APAC, linked to clear access, reimbursement, and adoption milestones in priority markets.
- Lead design and prioritization of clinical and economic studies (clinical outcomes, RWE, cost effectiveness, budget impact, pathway/resource use) that answer payer, HTA, hospital, and clinical decision-maker questions.
- Turn evidence into locally relevant value propositions, dossiers, slide decks, tools, and decision aids for payers, HTA bodies, hospital value committees, and clinical champions.
- Develop APAC access plans (e.g., HTA routes, innovation funding, direct payer contracting, hospital funding logic, coding/reimbursement context), and supply the Ion-specific evidence and analytics needed for submissions and negotiations, without owning pricing or commercial terms.
- Act as the regional Ion “go-to” for evidence & access.
- Build and maintain senior relationships with KOLs, professional societies, payers, HTA agencies, and hospital decision-makers; selectively engage in consultations, guidelines, registries, and collaborative studies that move adoption barriers.
- Provide leadership to direct reports and matrixed contributors. Select and manage HEOR/HTA/MA agencies, CROs, and data vendors. Own or co-own budgets and focus spend on initiatives with measurable access and adoption impact.
- Define and monitor KPIs (e.g., HTA decisions, time to funding, procedure volume, contribution of evidence programs). Use policy, competitive, and clinical-trend insights to refine the APAC strategy over time.
Requirements:
- Advanced clinical, scientific, or health-economics degree (e.g., MD, PharmD, PhD, MPH, MSc in life sciences, health economics, public health, or related field).
- 10+ years’ progressive experience in clinical and economic evidence, HEOR, and/or market access for medical devices or interventional technologies, with significant responsibility across multiple APAC markets.
- Proven track record contributing to successful reimbursement or funding outcomes in APAC (e.g., HTA submissions, innovation / pilot funding, coding or reimbursement changes, hospital funding decisions).
- Strong understanding of APAC healthcare systems, payer and HTA decision-making, and hospital financing/procurement.
- Ability to connect product and procedural details to outcomes, operational impact, and economic value – and to communicate that succinctly to senior clinical and non-clinical stakeholders.
- Demonstrated success leading regional or multi-country initiatives and influencing senior leaders in a matrix environment.
- Excellent written and verbal communication in English; proficiency in at least one major APAC language (e.g., Japanese, Korean, or Mandarin) strongly preferred.
Benefits:
- Health insurance
- Professional development opportunities
- Flexible work arrangements



















